SK Capital closes acquisition of Perrigo’s API business
SK Capital, a private investment firm focused on the specialty materials, chemicals and pharmaceuticals sectors, has completed its previously announced acquisition of Perrigo Company’s active pharmaceutical ingredients (API) business, which has been renamed from Perrigo API to Wavelength Pharmaceuticals (Wavelength). Wavelength is a leading developer and manufacturer of generic APIs